Fenimore Christopher R. sold REGN

February 9, 2024 · Form 4 insider transaction

Fenimore Christopher R. sold 600 shares of Regeneron Pharmaceuticals, Inc. at $955.00 per share, a transaction worth $573.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.